383 related articles for article (PubMed ID: 32669935)
21. External validation of the N descriptor in the proposed tumour-node-metastasis subclassification for lung cancer: the crucial role of histological type, number of resected nodes and adjuvant therapy.
Chiappetta M; Lococo F; Leuzzi G; Sperduti I; Petracca-Ciavarella L; Bria E; Mucilli F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F; Margaritora S
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1236-1244. PubMed ID: 32770184
[TBL] [Abstract][Full Text] [Related]
22. New N1/N2 classification and lobe specific lymphatic drainage: Impact on survival in patients with non-small cell lung cancer treated with surgery.
Tsitsias T; Okiror L; Veres L; King J; Harrison-Phipps K; Routledge T; Pilling J; Bille A
Lung Cancer; 2021 Jan; 151():84-90. PubMed ID: 33250210
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
[TBL] [Abstract][Full Text] [Related]
24. Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial.
Hui Z; Men Y; Hu C; Kang J; Sun X; Bi N; Zhou Z; Liang J; Lv J; Feng Q; Xiao Z; Chen D; Wang Y; Li J; Wang J; Gao S; Wang L; He J
JAMA Oncol; 2021 Aug; 7(8):1178-1185. PubMed ID: 34165501
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
[TBL] [Abstract][Full Text] [Related]
26. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial.
Le Pechoux C; Pourel N; Barlesi F; Lerouge D; Antoni D; Lamezec B; Nestle U; Boisselier P; Dansin E; Paumier A; Peignaux K; Thillays F; Zalcman G; Madelaine J; Pichon E; Larrouy A; Lavole A; Argo-Leignel D; Derollez M; Faivre-Finn C; Hatton MQ; Riesterer O; Bouvier-Morel E; Dunant A; Edwards JG; Thomas PA; Mercier O; Bardet A
Lancet Oncol; 2022 Jan; 23(1):104-114. PubMed ID: 34919827
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
[TBL] [Abstract][Full Text] [Related]
28. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
30. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
31. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
[TBL] [Abstract][Full Text] [Related]
32. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
33. The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy's efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients.
Zhang B; Zhao L; Yuan Z; Pang Q; Wang P
Onco Targets Ther; 2016; 9():6161-6169. PubMed ID: 27785064
[TBL] [Abstract][Full Text] [Related]
34. The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non-small Cell Lung Cancer.
Zhu F; Wang H; Ashamalla H
Clin Lung Cancer; 2022 Sep; 23(6):e384-e393. PubMed ID: 35676168
[TBL] [Abstract][Full Text] [Related]
35. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
Liu K; Chen HL; You QS; Huang JF; Wang H
Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
[TBL] [Abstract][Full Text] [Related]
37. Distribution and prognosis of mediastinal lymph node metastases of nonsmall cell lung cancer.
Guo D; Ni Y; Lv X; Zhang Z; Ye P
J Cancer Res Ther; 2016 Oct; 12(Supplement):120-125. PubMed ID: 27721268
[TBL] [Abstract][Full Text] [Related]
38. Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.
Wei W; Zhou J; Zhang Q; Liao DH; Liu QD; Zhong BL; Liang ZB; Zhang YC; Jiang R; Liu GY; Xu CY; Li Zhou H; Zhu SY; Yang N; Jiang W; Liu ZG
Cancer Med; 2020 Apr; 9(8):2820-2832. PubMed ID: 32100444
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for survival in patients with completely resected pN2 non-small-cell lung cancer.
Sezen CB; Aksoy Y; Sonmezoglu Y; Citak N; Saydam O; Metin M
Acta Chir Belg; 2021 Feb; 121(1):23-29. PubMed ID: 31437115
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
